SPONSORED | Using Metabolomic Analysis For Clinical Insight

So many of us in functional medicine use standard organic acid
interpretations, but newer research is using them in a broader
metabolomics assessment (the vast landscape of clinically relevant
metabolites). A great example is the assessment of in-born errors
of metabolism. Utilizing metabolomics resulted in a six-fold higher
diagnosis rate and identification of new in-born errors, compared
to traditional organic acid assessment methods. Impressive, isn’t
it? Think of what it could do in a full assessment. I’m thrilled to
be joined by my dear friend and metabolomics enthusiast Dr. Betsy
Redmond in today’s podcast. I worked with Dr. Redmond back at
Metametrix and deeply admire her passion and skill in bringing
metabolomics into clinical practice. With years of experience in
functional lab testing and a doctorate degree in nutrition, Dr.
Redmond shares exciting pearls from the latest metabolomics
research, including using urinary dicarboxylic acids to identify
early cognitive decline and strategies to modulate the kynurenine
tryptophan ratio (KTR) – a novel biomarker associated with
inflammation, cognitive decline, and kidney disease. I was excited
to hear that this ratio could also be used as an innovative
biological age marker – a topic at the center of my recently
published study on reversing epigenetic aging, and focus of my
book, Younger You. Thanks for listening to New Frontiers; please
leave us a review and comment to let us know what you think! ~DrKF